0

The full content of Annals is available to subscribers

Subscribe/Learn More  >
Editorials |

Sacubitril–Valsartan in Heart Failure: Why Are More Physicians Not Prescribing It?Sacubitril–Valsartan in Heart Failure ONLINE FIRST

Milton Packer, MD; W. Mark Armstrong, MD; Joseph M. Rothstein, MD; and Michael Emmett, MD
[+] Article, Author, and Disclosure Information

This article was published at www.annals.org on 30 August 2016.


From Baylor Heart and Vascular Institute and the Department of Medicine, Baylor University Medical Center, Dallas, Texas.

Disclosures: Disclosures can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M16-1932.

Requests for Single Reprints: Milton Packer, MD, Baylor Heart and Vascular Institute, Baylor University Medical Center, 621 North Hall Street, Dallas, TX 75226; e-mail, milton.packer@baylorhealth.edu.

Current Author Addresses: Dr. Packer: Baylor Heart and Vascular Institute, Baylor University Medical Center, 621 North Hall Street, Dallas, TX 75226.

Drs. Armstrong, Rothstein, and Emmett: Baylor University Medical Center, 3500 Gaston Avenue, Dallas, TX 75246.


Ann Intern Med. Published online 30 August 2016 doi:10.7326/M16-1932
© 2016 American College of Physicians
Text Size: A A A

Sandhu and colleagues' article supports the cost-effectiveness of sacubitril–valsartan in the treatment of heart failure. This analysis and others have reported favorable results associated with switching patients from conventional renin–angiotensin inhibitors to sacubitril–valsartan. The editorialists review the evidence for the benefits of this newer drug and explore reasons for what they believe is the slow adoption of sacubitril–valsartan in the management of heart failure.

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Letters

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Comments

Submit a Comment/Letter
We should step up to address the real problems!
Posted on August 30, 2016
Earl W. Ferguson, MD, PhD, FACC, FACPM, FACP
Ridgecrest Regional Hospital, Ridgecrest, CA
Conflict of Interest: None Declared

As a former academician and healthcare executive for 20 years who has been practicing medicine in a remote, under served area for 20 years, I have a different perspective. In the 40 years since I completed my training, medicine has markedly changed. It has become increasingly bureaucratic and far too expensive because of governmental,insurance company and other requirements. It is no longer the medicine I learned and enjoyed in the earlier part of my career, and still love and practice because I bailed out of the bureaucracy. The fault is our profession that has lost its independence because we did not take an active enough role in shaping our future. We should have done better, but we didn't meet the challenge. We've got to cut the bureaucracy and costs. Simpler, less expensive alternatives and better coordinated care to really transform American medicine is the only answer. Why spend so much for excessively expensive medications?

Earl W. Ferguson, MD, PhD, FACC, FACPM, FACP

ewferguson@sunbmt.com

Submit a Comment/Letter

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.

Toolkit

Buy Now for $32.00

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Advertisement
Related Articles
Related Point of Care
Topic Collections
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)